The present invention concerns the diagnosis and treatment of autoimmune demyelinating diseases, such as multiple sclerosis (MS), by means of a CLM-I agonist.La présente invention concerne le diagnostic et le traitement de maladies démyélinisantes autoimmunes telles que la sclérose en plaques (MS), au moyen dun agoniste CLM-1.